
Contents
-
-
-
-
-
-
-
-
-
-
-
-
Introduction Introduction
-
Public health genomic tests currently in use Public health genomic tests currently in use
-
Diagnostic genomic testing Diagnostic genomic testing
-
Predictive genomic testing Predictive genomic testing
-
Hereditary breast and ovarian cancer Hereditary breast and ovarian cancer
-
Newborn screening Newborn screening
-
Preimplantation and prenatal genetic testing Preimplantation and prenatal genetic testing
-
Pathogen genomics Pathogen genomics
-
-
Evaluation of genetic testing Evaluation of genetic testing
-
Pharmacogenomic testing Pharmacogenomic testing
-
Pharmacokinetic mechanism Pharmacokinetic mechanism
-
Pharmacodynamics mechanism Pharmacodynamics mechanism
-
Pharmacogenomics and drug development Pharmacogenomics and drug development
-
Epigenetic therapy Epigenetic therapy
-
Clinical conditions treated with epigenetic therapy Clinical conditions treated with epigenetic therapy
-
Advantages and disadvantages of epigenetic therapy Advantages and disadvantages of epigenetic therapy
-
Epigenomic technologies Epigenomic technologies
-
Epigenetic therapy in the future Epigenetic therapy in the future
-
-
Genome editing and public health Genome editing and public health
-
Meganucleases Meganucleases
-
Zinc finger nucleases (ZFNs) Zinc finger nucleases (ZFNs)
-
Transcription activator-like effector nucleases (TALENS) Transcription activator-like effector nucleases (TALENS)
-
CRISPR-Cas9 CRISPR-Cas9
-
CRISPR-based clinical trials CRISPR-based clinical trials
-
Advantages and limitations of CRISPR Advantages and limitations of CRISPR
-
Ethics of CRISPR Ethics of CRISPR
-
-
Ethical implications of genomics and public health Ethical implications of genomics and public health
-
Informed consent Informed consent
-
Prenatal screening Prenatal screening
-
Data storage and sharing Data storage and sharing
-
Storage of samples Storage of samples
-
-
Conclusion Conclusion
-
References References
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2.6 Genomics and public health
Get access-
Published:November 2021
Cite
Abstract
The discipline of ‘public health genomics’ emerged as a need to provide ‘responsible and effective translation of genome-based knowledge and technologies for the benefit of the population’. It is becoming increasingly accepted that the one size fits all approach is going to be outdated soon. Targeted personalized medicines, therapies, and interventions approach will be the preferred form of treatment in the not too distant future. The fields of public health genomics, precision medicine, and precision public health have proven important aspects in improving population health. However, despite the advancements made, there are still improvements that need to be implemented to significantly improve health, especially within the developing countries. In this chapter we discuss the advancements made within the field and highlight challengers or future directions.
Sign in
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Purchase
Our books are available by subscription or purchase to libraries and institutions.
Purchasing informationMonth: | Total Views: |
---|---|
October 2022 | 7 |
November 2022 | 7 |
December 2022 | 10 |
January 2023 | 5 |
February 2023 | 8 |
March 2023 | 8 |
April 2023 | 11 |
May 2023 | 10 |
June 2023 | 11 |
July 2023 | 12 |
August 2023 | 14 |
September 2023 | 15 |
October 2023 | 12 |
November 2023 | 4 |
December 2023 | 3 |
January 2024 | 3 |
February 2024 | 1 |
March 2024 | 9 |
April 2024 | 3 |
May 2024 | 10 |
June 2024 | 8 |
July 2024 | 4 |
August 2024 | 9 |
September 2024 | 1 |
October 2024 | 7 |
November 2024 | 7 |
January 2025 | 6 |
February 2025 | 3 |
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.